- 全部删除
您的购物车当前为空
Ro3280 (Ro5203280) 是一种高度选择性的PLK1抑制剂,IC50和Kd 值分别为 3 nM 和 0.09 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
Ro3280 (Ro5203280) 是一种高度选择性的PLK1抑制剂,IC50和Kd 值分别为 3 nM 和 0.09 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 613 | In stock | |
| 5 mg | ¥ 1,320 | In stock | |
| 10 mg | ¥ 2,130 | In stock | |
| 25 mg | ¥ 3,590 | In stock | |
| 50 mg | ¥ 5,180 | In stock | |
| 100 mg | ¥ 7,330 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,580 | In stock |
Ro3280 相关产品
| 产品描述 | Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM). |
| 靶点活性 | MYLK:170 nM (Kd), DAPK1:100 nM (Kd), PTK2 (Protein Tyrosine Kinase 2):84 nM (Kd), DAPK3:70 nM (Kd), PTK2B (Protein Tyrosine Kinase 2B):130 nM (Kd), CAMKK2:87 nM (Kd), ALK:230 nM (Kd), GAK:87 nM (Kd), PLK1:3 nM, CAMKK1:1100 nM (Kd), TTK:51 nM (Kd), RPS6KA6 (KinDom.2):560 nM (Kd), FER:53 nM (Kd) |
| 体外活性 | 在植入HT-29人大肠肿瘤的裸鼠中,RO3280(40 mg/kg)能够抑制肿瘤细胞增殖. |
| 体内活性 | RO3280对于多种瘤细胞株具有抗肿瘤活性,对于肺癌细胞株H82(IC50=5 nM),大肠癌细胞HT-29(IC50=10 nM),乳腺癌细胞MDA-MB-468(IC50=19 nM),前列腺癌细胞PC3(IC50=12 nM)和皮肤癌细胞A375(IC50=70 nM)能够抑制肿瘤细胞增殖。 |
| 别名 | Ro5203280, RO 3280 |
| 分子量 | 543.61 |
| 分子式 | C27H35F2N7O3 |
| CAS No. | 1062243-51-9 |
| Smiles | COc1cc(ccc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1)C(=O)NC1CCN(C)CC1 |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 27.2 mg/mL (50.04 mM), Sonication is recommended. Ethanol: 27.2 mg/mL (50.04 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO/Ethanol
| |||||||||||||||||||||||||||||||
评论内容